Cargando…
A Case Report of Compound Heterozygous CYP24A1 Mutations Leading to Nephrolithiasis Successfully Treated with Ketoconazole
CYP24A1 is an enzyme that inactivates vitamin D. Loss-of-function mutations in this enzyme are rare but have been linked with idiopathic infantile hypercalcemia as well as adult-onset nephrocalcinosis and nephrolithiasis. Genetic testing for this mutation should be considered in the presence of calc...
Autores principales: | Davidson Peiris, Emma, Wusirika, Raghav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803692/ https://www.ncbi.nlm.nih.gov/pubmed/29457022 http://dx.doi.org/10.1159/000485243 |
Ejemplares similares
-
Compound Heterozygous Mutation of Rag1 Leading to Omenn Syndrome
por: Matthews, Adam G. W., et al.
Publicado: (2015) -
AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT
por: Trutin, Ivana, et al.
Publicado: (2021) -
Ketoconazole Allergy
por: Ensina, Luis Felipe, et al.
Publicado: (2009) -
Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers
por: Teng, Renli, et al.
Publicado: (2013) -
When a maternal heterozygous mutation of the CYP24A1 gene leads to infantile hypercalcemia through a maternal uniparental disomy of chromosome 20
por: Hureaux, Marguerite, et al.
Publicado: (2021)